Categories: HealthcareNewsSeniors

InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference

DENVER, Dec. 30, 2025 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced that CEO Patrick Blair will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 9:45 a.m. (PT) / 12:45 p.m. (ET). The presentation and audio will be webcast live, and the webcast link and related presentation materials for the event will be available online on the investor relations section of the Company’s website.

About InnovAge
InnovAge is a market leader in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care our participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers and government payors — “win.” As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states. https://www.innovage.com.

Investor Contact:
Ryan Kubota
rkubota@innovage.com

Media Contact:
Lara Hazenfield
lhazenfield@innovage.com

This press release was published by a CLEAR® Verified individual.

Staff

Recent Posts

Qiming Venture Partners’ Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug…

14 minutes ago

Entering the New Year, VARON Strengthens Commitment to Dependable Oxygen Support

NEW YORK, Dec. 30, 2025 /PRNewswire/ -- As the new year begins, it offers a…

14 minutes ago

MedMira Reports First Quarter Results FY2026

HALIFAX, NOVA SCOTIA / ACCESS Newswire / December 30, 2025 / MedMira Inc. (MedMira) (TSXV:MIR),…

3 hours ago

Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor

PETAH TIKVA, Israel & BOCA RATON, Fla.--(BUSINESS WIRE)--#24hourABPM--Biobeat Technologies, Ltd., developer of the first FDA-cleared,…

6 hours ago

KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

6 hours ago

NGD Infection Prevention Deploys NGD200 System to the Largest Medical Center in the Middle East

CAMBRIDGE, Mass., Dec. 30, 2025 /PRNewswire/ -- NGD Infection Prevention, a global provider of real-time genomic…

6 hours ago